<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180109038285N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-01</date_registration>
      <primary_sponsor>National Institute for Medical Research Development</primary_sponsor>
      <public_title>The comparative effects of comprehensive protocol and routine physical therapy on pain, balance, disability and quality of life in patient with ankle sprain</public_title>
      <acronym></acronym>
      <scientific_title>The comparative effects of comprehensive protocol and routine physical therapy on pain, balance, disability and quality of life in patient with chronic ankle instability</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-07-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60382</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: in order to have equal number of participants, the random allocation of participants into two groups utilized the balanced block randomization method. 

In the present study, block randomization was run within blocks of four, there are six possible ways to equally assign participants to a block (A: intervention group; B: control group). All possible modes of the four blocks were written and numbered as follows: 1. AABB; 2. ABAB; 3. BBAA; 4. BABA; 5. ABBA; 6. BAAB. Consequently, in each block, two participants were assigned to the intervention group and two were assigned to the comparison group. The allocation sequence was prepared using the randomizer.org website before starting the study, with letter A for the intervention group and the letter B for the control group. The allocation sequence was prepared using the randomizer.org website before starting the study, with letter A for the intervention group and the letter B for the control group. 

In order to conceal the allocation sequence, 60 opaque envelopes were prepared, Blinding description: This study was performed in a double-blind manner so that the  physiotherapist who performed the pre- and post-test was not involved in the treatment process, and in addition the person who analyzed the data was blind from the grouping allocation.</study_design>
      <phase>3</phase>
      <hc_freetext>Chronic ankle instability.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: It involved up to twelve face-to-face sessions over four weeks and each session last for approximately 45 minutes. Patients in the comprehensive group, during the four-week program, received a combination of specific exercises modified from updated evidence-based randomized controlled trials and conventional physiotherapy protocol. Intervention 2: Intervention group:  It involved up to twelve face-to-face sessions over four weeks and each session last for approximately 45 minutes. Patients in the conventional group received exercises from standard physiotherapy which has been done in most randomized controlled trials elaborated in recent systematic reviews. Ankle strengthening (isometric, concentric, eccentric, weight bearing, and non-weight bearing), stretching, and retraining exercise and talocrural and subtalar mobilization were done each session.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Information on the assessed outcome after publishing the article, is available

When:
Start of access period 6 months after printing

To whom:
Researchers working in academic and scientific institutions

Conditions:
In order to find a better way to treat ankle sprains, the data will be used after the article is published.

Where to obtain:
Dr. Hossein Neghaban
honegahban@yahoo.com

How to obtain:
If the applicant needs the data, he / she will receive the data after giving an electronic message to Dr. Hossein Neghaban, and at his / her discretion.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein Negahban</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khorasan Razavi, Mashhad, Azadi Square, east door of the university campus</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948564</zip>
        <telephone>+98 51 3800 2000</telephone>
        <email>honegahban@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hossein Negahban</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Khorasan Razavi, Mashhad, Azadi Square, east door of the university campus</address>
        <city>ئشسااشی</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948564</zip>
        <telephone>+98 51 3800 2000</telephone>
        <email>honegahban@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>History of unilateral chronic ankle instability
Answer “yes” to at least five Yes/No questions of 9 questions of Persian-version of ankle instability instrument
Age between 18-68 year</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>68 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>severe or constant pain and swelling
radicular pain from the lumbar or buttock region
history of lower extremity surgery
lower extremity fracture
ankle fracture or surgery</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: It involved up to twelve face-to-face sessions over four weeks and each session last for approximately 45 minutes. Patients in the comprehensive group, during the four-week program, received a combination of specific exercises modified from updated evidence-based randomized controlled trials and conventional physiotherapy protocol</i_keyword>
      <i_keyword>Intervention group:  It involved up to twelve face-to-face sessions over four weeks and each session last for approximately 45 minutes. Patients in the conventional group received exercises from standard physiotherapy which has been done in most randomized controlled trials elaborated in recent systematic reviews. Ankle strengthening (isometric, concentric, eccentric, weight bearing, and non-weight bearing), stretching, and retraining exercise and talocrural and subtalar mobilization were done each session.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Disability. Timepoint: Before starting physiotherapy and after completing physiotherapy sessions. Method of measurement: FAAM and FAOS questionnaires.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain. Timepoint: Pre-intervention and immediately after finishing the physiotherapy sessions. Method of measurement: Visual Analog Scale.</sec_outcome>
      <sec_outcome>Range of motion. Timepoint: Pre-intervention and immediately after physiotherapy sessions. Method of measurement: Calibrated goniometer.</sec_outcome>
      <sec_outcome>Balance. Timepoint: Pre-intervention and immediately after physiotherapy sessions. Method of measurement: Star excursion balance test.</sec_outcome>
      <sec_outcome>Treatment effectiveness. Timepoint: Immediately after the physiotherapy sessions. Method of measurement: Global rating of change.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id>IR.NIMAD.REC.1397.008</sec_id>
        <issuing_authority>National Institute for medical research Development  (NIMAD)</issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National Institute for Medical Research Development</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-07-01</approval_date>
        <contact_name>Ethics committee of National Institute for Medical Research Development</contact_name>
        <contact_address>West Fatemi Street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
